Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysisKazem Rahimi, Barry R. Davis, Takayoshi Ohkubo et al.|The Lancet|2021Cited by 997
Effect of Amlodipine on the Progression of Atherosclerosis and the Occurrence of Clinical EventsBertram Pitt, Published by the European Mathematical Society with the support of the Schweizerische Akademie der Naturwissenschaften and the Stiftung zur Förderung der mathematischen Wissenschaften in der Schweiz., Robert P. Byington et al.|Circulation|2000Cited by 668
Additive Benefits of Pravastatin and Aspirin to Decrease Risks of Cardiovascular DiseaseCharles H. Hennekens, René Belder, Frank M. Sacks et al.|Archives of Internal Medicine|2004Cited by 111
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: Randomized and observational comparisons of secondary prevention trials and their meta-analysisCharles H. Hennekens, René Belder, Frank M. Sacks et al.|Journal of the American College of Cardiology|2003Cited by 6